Biotechnology News

October 1, 2014

BALTIMORE--(BUSINESS WIRE)--GVN launches Business Leadership Council, a unique initiative to engage corporate executives and business leaders in the fight against pandemic viral threats.

October 1, 2014

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced that it has opened six new clinical trials in 2014, and is on track to open more multiple myeloma clinical trials during 2014.

October 1, 2014

BOSTON--(BUSINESS WIRE)--On September 30, 2014, H&Q Life Sciences Investors paid a quarterly stock distribution of $0.45 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of...

October 1, 2014

BOSTON--(BUSINESS WIRE)--On September 30, 2014, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition...

October 1, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that 25 abstracts...

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Third Quarter on October 24

October 1, 2014

FAIRFIELD, N.J.--(BUSINESS WIRE)--The Healthcare Businesswomen's Association (HBA) has named Baxter International’s Baxter Women Leaders (BWL) business resource group as the winner of the 2014 HBA ACE award. HBA created the award to recognize...

October 1, 2014

TOULOUSE, France--(BUSINESS WIRE)--AMATSIGROUP, a dedicated service provider in both human and veterinary drug development sectors, announces the establishment of an operation site in the US in Terre Haute (Indiana).

October 1, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) and its subsidiary LifeMap Solutions, Inc., a medical technology company, today announced significant additions to the LifeMap Solutions management team. LifeMap Solutions is...

October 1, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Gil Yosipovitch, M.D. joins Clinical Advisory Board at Trevi Therapeutics.

October 1, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero...

October 1, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2014 before the market opens on Wednesday, October 22,...

October 1, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) will host a conference call and live audio webcast on Thursday, October 23, 2014 at 9 a.m. ET to discuss third quarter 2014 financial and operational results. The webcast can be...

October 1, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides has started IND-enabling safety/Toxicology studies of its Injectable FluCide(tm) drug candidate at BASi. The Company has also started making drug candidates for evaluation against Ebola.

October 1, 2014

PERKASIE, Pa.--(BUSINESS WIRE)--Chris Glasby, Senior Manufacturing Engineer at Secant Medical, will present “Existing Textile Technology Matched with Material Innovation” during the medical track at the IFAI Advanced Textiles Expo.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company today announced the recipients of the 2014 Genzyme Patient Advocacy Leadership (PAL) Awards.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators from the American Porphyria Consortium and The European Porphyria Network have initiated the EXPLORE trial, a...

October 1, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that the company...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma to host and webcast an online educational seminar on beta-thalassemia. Company is conducting phase 2 clinical trials of sotatercept and luspatercept in patients with the disease.

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its...

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Stemedica Cell Technologies, Inc. was issued a new patent from the U.S. Patent & Trademark Office entitled “Composition of Stem Cells and Stem Cell Factors for Their Use and Manufacture.”

October 1, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today disclosed results from recent studies further confirming CGEN-15049 as a promising target candidate for cancer immunotherapy

October 1, 2014

FAIRFAX, Va.--(BUSINESS WIRE)--ICF wins new $12 million contract with CDC to provide support for multiple aspects of CDC's BioSense program.

October 1, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Audentes Therapeutics announces the continued expansion of its management team, including the appointment of John T. Gray as Vice President, Research and Development

October 1, 2014

DALLAS--(BUSINESS WIRE)--MD Buyline released the results of the Q3.2014 “User Satisfaction Trending™” survey to MD Buyline members. Half of the nation’s hospitals rely on this information to make informed, evidence-based decisions on healthcare...

October 1, 2014

TOKYO--(BUSINESS WIRE)--Tokyo Electron Limited (TEL) opened, through its European subsidiary Tokyo Electron Europe Limited (TEE), the company’s open innovation centre at Stevenage Bioscience Catalyst (SBC) in the United Kingdom. The goal is to...

October 1, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--The public exhibition (Longyan Station) of the ‘China (Zhangjiajie) Giant Salamander’ was held in Sunrise City Mall, Longyan, Fujian Province, China from 19 September to 21 September 2014. It was co-organized...

October 1, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides has filed its financial year end annual report (Form 10-K) with the SEC yesterday.

October 1, 2014

BRISBANE, Australia--(BUSINESS WIRE)--iMDsoft will be presenting MetaVision Anaesthesia, our advanced Anaesthesia Information Management System, at ASA NSC in Gold Coast from the 4th to 7th October.

October 1, 2014

YOKOHAMA, Japan--(BUSINESS WIRE)--Business Wire is the official media partner for the BioJapan 2014. Breaking news releases, online press kits are available at Tradeshownews.com.

October 1, 2014

WASHINGTON--(BUSINESS WIRE)--The lack of context in CMS’s Sunshine data threatens health care innovation.

October 1, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD granted two new patents

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced a leadership reorganization under which the Board of Directors has appointed Stephen Aselage as interim Chief Executive Officer (CEO), effective immediately, to replace...

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Transfer $1.4 Billion in U.S. Pension Obligations to Prudential

October 1, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Project Xenon Press Release - September 30, 2014

October 1, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

September 30, 2014

ROCHESTER, N.Y.--(BUSINESS WIRE)--ACM Medical Laboratory’s VP of Scientific Affairs and Laboratory Operations Continues her Role as Senior Editor to Update Leading Laboratory Testing Textbook for Global Provider Community

September 30, 2014

PARIS--(BUSINESS WIRE)--Cellectis: First-half 2014 financial results

A successful therapeutic focus
A drastic reduction of its operating expenses

September 30, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH  (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

September 30, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--KAI Research, Inc. (KAI), a wholly owned subsidiary of Altarum Institute, announced today that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult,...

September 30, 2014

WASHINGTON--(BUSINESS WIRE)--Key stakeholders in the diabetes industry convened in Washington D.C. on Sept. 28-29 for the AACE/ACE Consensus Conference on Glucose Monitoring to address current barriers to optimal diabetes care.

September 30, 2014

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix raises over $15 million to fund pivotal clinical trial and final product development of eye test designed to identify early-stage Alzheimer’s Disease

September 30, 2014

BERKELEY HEIGHTS & PARSIPPANY, N.J.--(BUSINESS WIRE)--Edge Therapeutics, Inc. and Evonik Corporation announced that they have received a U.S. Patent expiring July 2033 covering EG-1962, Edge’s lead product candidate.

September 30, 2014

BARCELONA, Spain--(BUSINESS WIRE)--GE Healthcare is highlighting its industry leading credentials and new innovations in Intensive Care Medicine at the European Society of Intensive Care Medicine (ESICM) annual congress in Barcelona this week....

September 30, 2014

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that in conjunction with its Fiscal 2015 First Quarter release, you are invited to participate in the conference call on Thursday, October 9, 2014 at 9:00 a.m. Eastern. Individuals...

September 30, 2014

NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (CSE:HSM) is pleased to announce that it has completed the Commercial Design Specification phase of its commercial version of the Portable Neuromodulation Stimulator

September 30, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive...

September 30, 2014

SEATTLE--(BUSINESS WIRE)--LabConnect, LLC., a leading provider of central laboratory services to the biopharmaceutical industry, announces the release of its BioVisualization software platform.

September 30, 2014

NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the addition of James E. Darnell, Jr., M.D., Vincent Astor Professor...